Latest other medicines regulatory guidance
-
17 Feb 2011 | Best Practice in Reporting of Individual Case Safety Reports (ICSRs)
We have today published guidance for industry that sets the MHRA's position on how to code adverse drug reactions (ADRs) to a high-quality standard for entry into our Sentinel database. This ‘Best Practice’ guide has been developed combining ideas from both industry trade associations and the MHRA.
-
03 Feb 2011 | Best practice for ensuring the efficient supply and distribution of medicines to patients
This guidance has been developed and is supported by eleven organisations, including the MHRA, following detailed consideration of the current problems with the supply chain, especially those caused by increased exports of medicines from the UK.
-
24 Aug 2009 | Guidance on completion of GMP QC Lab change form - April 2009
(81Kb)
-
24 Aug 2009 | Introduction of a Risk Based Inspection Programme for GMP QC Labs
(47Kb)
-
24 Aug 2009 | GMP QC Lab Notification of Change form
(666Kb)
-
24 Aug 2009 | Use of test sites in Canada
(38Kb)
-
01 Apr 2009 | New guidance on consumer advertising for registered traditional herbal medicines
We have produced guidance for companies advertising registered traditional herbal medicines to the public.
-
13 Mar 2009 | Inspected UK Contract GMP Quality Control Laboratories
(94Kb)
-
22 Oct 2008 | Good Pharmacovigilance Practice Guide
We are pleased to announce the publication of the ‘Good Pharmacovigilance Practice Guide’ which is intended to complement currently available legislation and guidance, and to provide practical advice about achieving an appropriate system of pharmacovigilance.
-
21 Nov 2007 | Maintaining High Standards in Medicines Advertising Regulation - Annual Report September 2006 - August 2007
(156Kb)
